Table 2.
LncRNA | Reference | Samples | Tissue | Change of expression |
---|---|---|---|---|
ANRIL | Sathishkumar et al. (21) | T2DM patients | PBMCs | Up |
Toraih et al. (63) | T2DM patients | Plasma | Up | |
Zhang and Wang (77) | T2DM patients | Serum | Up | |
GAS5 | Carter et al. (23) | T2DM patients | Serum | Down |
Esguerra et al. (43) | T2DM patients | Pancreatic islets | Up | |
Sathishkumar et al. (21) | T2DM patients | PBMCs | Up | |
H19 | Cheng et al. (39) | T2DM patients | Peripheral blood | Up |
Fawzy et al. (45) | T2DM patients | Plasma | Up | |
Gao et al. (46) | T2DM patients | Muscle | Down | |
HOTAIR | Li et al. (49) | T2DM patients | Liver | Up |
Sathishkumar et al. (21) | T2DM patients | PBMCs | Up | |
Shaker et al. (62) | T2DM patients | Blood | Up | |
Kcnq1ot1 | Móran et al. (56) | T2DM patients | Pancreatic islets | Up |
Yang et al. (68) | DM patients | Serum | Up | |
Yang et al. (69) | DM patients | Serum | Up | |
MALAT1 | Liu et al. (52) | T2DM patients | Serum | Up |
Luo et al. (53) | T2DM patients | Blood | Up | |
Sathishkumar et al. (21) | T2DM patients | PBMCs | Up | |
Shaker et al. (62) | T2DM patients | Blood | Up | |
Toraih et al. (63) | T2DM patients | Plasma | Up | |
MEG3 | Kameswaran et al. (48) | T2DM patients | Pancreatic islets | Down |
Luo et al. (53) | T2DM patients | Blood | Down | |
Sathishkumar et al. (21) | T2DM patients | PBMCs | Up | |
Zhang et al. (74) | DM patients | Serum | Down | |
MIAT | De Gonzalo-Calvo et al. (42) | T2DM patients | Serum | Up |
Sathishkumar et al. (21) | T2DM patients | PBMCs | Up | |
Toraih et al. (63) | T2DM patients | Plasma | Up |
DM, diabetes mellitus; PBMCs, Peripheral blood mononuclear cells; T2DM, type 2 diabetes mellitus.